Artificial intelligence revolutionizing drug development: Exploring opportunities and challenges

Abstract

By harnessing artificial intelligence (AI) algorithms and machine learning techniques, the entire drug discovery process stands to undergo a profound transformation, offering a myriad of advantages. Foremost among these is the ability of AI to conduct swift and efficient screenings of expansive compound libraries, significantly augmenting the identification of potential drug candidates. Moreover, AI algorithms can prove instrumental in predicting the efficacy and safety profiles of candidate compounds, thus endowing invaluable insights and reducing reliance on extensive preclinical and clinical testing. This predictive capacity of AI has the potential to streamline the drug development pipeline and enhance the success rate of clinical trials, ultimately resulting in the emergence of more efficacious and safer therapeutic agents. However, the deployment of AI in drug discovery introduces certain challenges that warrant attention. A primary hurdle entails the imperative acquisition of high‐quality and diverse data. Furthermore, ensuring the interpretability of AI models assumes critical importance in securing regulatory endorsement and cultivating trust within scientific and medical communities. Addressing ethical considerations, including data privacy and mitigating bias, represents an additional momentous challenge, requiring assiduous navigation. In this review, we provide an intricate and comprehensive overview of the multifaceted challenges intrinsic to conventional drug development paradigms, while simultaneously interrogating the efficacy of AI in effectively surmounting these formidable obstacles.

Artificial intelligence utility for drug development: ChatGPT and beyond

“…In conclusion, GPT-based AI tools have great potential to facilitate the complex, expensive, and time-consuming drug development process by identifying the most promising drug targets and potential lead compounds (Tiwari et al, 2023;Turon et al, 2023). Improved GPT-based tools will be coming, and the pharma R&D sector will need to identify and prioritize the optimal modes for using them.…”

Transformative trends: A comprehensive review on role of artificial intelligence in healthcare and pharmaceutical research

“…45 To overcome these challenges, computer models and artificial intelligence (AI) technologies have developed as viable tools for forecasting drug pharmacokinetics and pharmacodynamics, providing a faster, more cost-effective, and accurate approach. 46 AI has shown significant promise in the disciplines of pharmacokinetics, pharmacodynamics, and drug discovery. AI has proved useful in predicting and optimizing medication pharmacokinetics and pharmacodynamics as robust computing and machine learning methods have evolved.…”

Assessing Riverbank Change Caused by Sand Mining and Waste Disposal Using Web-Based Volunteered Geographic Information

“…VGI has shown immense potential in supplementing traditional authoritative data sources, offering updated, detailed, and context-rich information [58]. However, challenges persist regarding data quality, standardization, accuracy, and robust validation methods [59]. Despite these challenges, VGI has proven instrumental in various fields, including disaster management, urban planning, conservation, and public health, significantly democratizing geospatial information [60,61].…”